Profile

Joyce Schroeder

Professor, Genetics - GIDP | Member of the Graduate Faculty | Professor, BIO5 Institute | Professor, Molecular and Cellular Biology | Professor, Cancer Biology - GIDP

Molecular and Cellular Biology

Full Page

Overview

Research

Collaboration(39)

Page 1 of 8

Grants(14)

Induction of Lysosomal Trafficking to Target Growth and Metastasis
2018·$556.6K·
External
Principal Investigator (PI)
lysosomal trafficking, cancer metastasis, cell growth, induction, molecular targeting
STTR: Combinatorial Inactivation of ERBB Receptors In Breast Cancer using Therapeutic Stapled Peptides
2016·$149.1K·
External
Principal Investigator (PI)
breast cancer, therapeutic peptides, erbb receptors, combinatorial inactivation, sttr
Decoy Peptides: Development of a Novel Therapeutic for Metastatic Cancer
2013·$70.3K / $100.5K·
External
Principal Investigator (PI)
peptide therapeutics, cancer treatment, metastatic cancer, drug development, therapeutic peptides
Theranostic Development for the Treatment of Metastatic Breast Cancer
2012·$84.1K / $112.1K·
External
Principal Investigator (PI)
theranostic development, metastatic breast cancer, treatment, development, breast cancer
Theranostic Development for the Treatment of Metastatic Breast Cancer
2011·$84.4K / $112.5K·
External
Principal Investigator (PI)
theranostic, metastatic breast cancer, treatment, development, breast cancer

Page 1 of 3

Publications(56)

Recent

Nuclear epidermal growth factor receptor as a therapeutic target

2023

cancer, therapeutics, molecular biology, cell signaling, radiation therapy

Application of Microfluidic Systems for Breast Cancer Research

2022

microfluidics, breast cancer, cancer research, biomedical engineering, lab-on-a-chip

Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors

2022

breast cancer, chemokines, cell migration, receptor cross talk, gene ing4

Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor

2022

cancer, therapeutics, epidermal growth factor, protein targeting, cell signaling

Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization

2019

cancer metastasis, retrograde trafficking, receptor mislocalization, cellular trafficking, cancer biology

Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer

2019

cancer, peptide therapy, egfr, inflammatory breast cancer, her2 inhibition

mediates the role of Lethal giant larvae as an epithelial growth inhibitor in

2018

cell growth, epithelial development, protein mediation, tumor suppression, cell polarity

Wrong Place at the Wrong Time: How Retrograde Trafficking of Receptor Tyrosine Kinases Drives Cancer Metastasis

2018

cancer metastasis, retrograde trafficking, receptor tyrosine kinases, cancer, cell signaling

Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration

2017

cell signaling, cancer biology, molecular biology, cell biology, protein trafficking

em miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila

2017

micrornas, epithelial growth, drosophila genetics, cell polarity, tumor suppression

People

Profile

Joyce Schroeder

Collaboration(39)

H-H. Sherry Chow

Cynthia Thomson

Bonnie LaFleur

Denise Roe

David Besselsen

Grants(14)

Induction of Lysosomal Trafficking to Target Growth and Metastasis

STTR: Combinatorial Inactivation of ERBB Receptors In Breast Cancer using Therapeutic Stapled Peptides

Decoy Peptides: Development of a Novel Therapeutic for Metastatic Cancer

Theranostic Development for the Treatment of Metastatic Breast Cancer

Theranostic Development for the Treatment of Metastatic Breast Cancer

Publications(56)

Nuclear epidermal growth factor receptor as a therapeutic target

Application of Microfluidic Systems for Breast Cancer Research

Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors

Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor

Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization

Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer

mediates the role of Lethal giant larvae as an epithelial growth inhibitor in

Wrong Place at the Wrong Time: How Retrograde Trafficking of Receptor Tyrosine Kinases Drives Cancer Metastasis

Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration

em miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila